6.17
price up icon17.30%   0.91
 
loading
Schlusskurs vom Vortag:
$5.26
Offen:
$5.76
24-Stunden-Volumen:
3.60M
Relative Volume:
13.17
Marktkapitalisierung:
$12.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.52M
KGV:
-2.9522
EPS:
-2.09
Netto-Cashflow:
$-45.03M
1W Leistung:
+23.65%
1M Leistung:
+1,224%
6M Leistung:
+649.70%
1J Leistung:
+290.51%
1-Tages-Spanne:
Value
$5.3101
$6.42
1-Wochen-Bereich:
Value
$4.91
$6.42
52-Wochen-Spanne:
Value
$0.224
$6.42

Nextcure Inc Stock (NXTC) Company Profile

Name
Firmenname
Nextcure Inc
Name
Telefon
240-399-4900
Name
Adresse
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Name
Mitarbeiter
43
Name
Twitter
@nextcureinc
Name
Nächster Verdiensttermin
2025-03-07
Name
Neueste SEC-Einreichungen
Name
NXTC's Discussions on Twitter

Vergleichen Sie NXTC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NXTC
Nextcure Inc
6.17 12.30M 0 -58.52M -45.03M -2.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-11-04 Herabstufung Ladenburg Thalmann Buy → Neutral
2022-03-01 Eingeleitet Ladenburg Thalmann Buy
2021-03-05 Hochstufung Truist Hold → Buy
2021-01-15 Herabstufung BofA Securities Neutral → Underperform
2020-07-16 Hochstufung The Benchmark Company Hold → Buy
2020-07-13 Herabstufung ROTH Capital Buy → Neutral
2020-07-13 Herabstufung SunTrust Buy → Hold
2020-06-01 Herabstufung BofA/Merrill Buy → Neutral
2020-06-01 Herabstufung The Benchmark Company Buy → Hold
2020-05-26 Eingeleitet JMP Securities Mkt Outperform
2020-03-24 Eingeleitet The Benchmark Company Buy
2020-03-02 Eingeleitet ROTH Capital Buy
2020-01-13 Eingeleitet SunTrust Buy
2019-12-05 Eingeleitet Needham Buy
2019-11-26 Eingeleitet BTIG Research Buy
2019-07-09 Eingeleitet BofA/Merrill Buy
2019-06-03 Eingeleitet Morgan Stanley Overweight
2019-06-03 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Nextcure Inc Aktie (NXTC) Neueste Nachrichten

pulisher
Jul 25, 2025

Is NextCure Inc. a good long term investmentGame-changing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

NXTC Stock: Exploring Nextcure Inc’s Growth - investchronicle.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives NextCure Inc. stock priceConsistent double returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

NextCure stock soars after positive data for bone disease treatment - Investing.com India

Jul 25, 2025
pulisher
Jul 25, 2025

NextCure Soars On Encouraging Preclinical Data Of Brittle Bone Disease Drug Candidate - Nasdaq

Jul 25, 2025
pulisher
Jul 25, 2025

NextCure Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about NextCure Inc. stockSuperior return velocity - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment - MSN

Jul 25, 2025
pulisher
Jul 24, 2025

How NextCure Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

NextCure, Inc. Presents Promising Preclinical Data for NC605 in Osteogenesis Imperfecta at Brittle Bone Society Meeting - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta - The Manila Times

Jul 24, 2025
pulisher
Jul 16, 2025

What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India

Jul 15, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure Implements Reverse Stock Split on Nasdaq - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com

Jul 14, 2025
pulisher
Jul 10, 2025

NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks

Jul 10, 2025

Finanzdaten der Nextcure Inc-Aktie (NXTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):